ArticleScience translational medicine2017
An automated smartphone-based diagnostic assay for point-of-care semen analysis.
Article in Science translational medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
65 citing papers in PubMed, 1 synthesis or guideline pooled it, 190 citations in OpenAlex.
- Artificial intelligence (AI) approaches to male infertility in IVF: a mapping review.European journal of medical research · 2025Pooled it
- Ability and accuracy of the smartphone-based O`VIEW-M® sperm test: Useful tool in the era of Covid-19.PloS one · 2022Trial
- Development of a Noble On-Site Dual Screening System for Male Fertility of Sperm Count and Hyaluronidase Activity.The world journal of men's health · 2026Article
- Artificial intelligence in infertility treatment: Applications, challenges, and future directions: A narrative review.International journal of reproductive biomedicine · 2026Review
- Perfluorooctane sulfonic acid impairs spermatogenesis via the liver-gut microbiota-testis axis: a central role of chenodeoxycholic acid metabolism.Journal of advanced research · 2026Article
- Microfluidics for in vitro fertilization: from science to clinical validation.Human reproduction update · 2026Review
- Cost Considerations of Direct to Consumer Infertility Testing and Sperm Cryopreservation.Current urology reports · 2026Review
- Pregnancy AI: Development and Internal Validation of an Artificial Intelligence Tool to Predict Live Births in ICSI and IVF Cycles Using Clinical Features and Embryo Images.Medicina (Kaunas, Lithuania) · 2026Article
- AI-Supported Digital Microscopy Diagnostics in Primary Health Care Laboratories: Scoping Review.Journal of medical Internet research · 2026Article
- Implementation readiness of artificial intelligence inFrontiers in endocrinology · 2026Review
- Comparing remote smartphone-based semen assessments with laboratory evaluations in men unselected for fertility concerns.Fertility and sterility · 2025Article
- A Mobile Sperm Analyzer with User-Friendly Microfluidic Chips for Rapid On-Farm Semen Evaluation.Biosensors · 2025Article
- The integration of artificial intelligence in assisted reproduction: a comprehensive review.Frontiers in reproductive health · 2025Review
- Artificial Intelligence in IVF Laboratories: Elevating Outcomes Through Precision and Efficiency.Biology · 2024Review
- Can Microfluidics Improve Sperm Quality? A Prospective Functional Study.Biomedicines · 2024Article
- Introducing a New Smartphone Applied Semen Analyzer, SpermCell™: A Cross-Sectional Validation Study with a Comparative Analysis and a Mini Patient Questionnaire on a Large Sample Cohort.Diagnostics (Basel, Switzerland) · 2024Article
- Microfluidic chip as a promising evaluation method in assisted reproduction: A systematic review.Bioengineering & translational medicine · 2024Review
- Advancing biological investigations using portable sensors for detection of sensitive samples.Heliyon · 2023Review
- Performance evaluation of sperm concentration, motility, and morphological analysis for GSA-810 series of sperm quality analysis system.Journal of clinical laboratory analysis · 2023Article
- Male infertility: what on earth is going on? Pilot international questionnaire study regarding clinical evaluation and fertility treatment for men.Reproduction & fertility · 2023Article
5 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
10 authors at 2 institutions in 1 country.
Funding
Abstract
Male infertility affects up to 12% of the world's male population and is linked to various environmental and medical conditions. Manual microscope-based testing and computer-assisted semen analysis (CASA) are the current standard methods to diagnose male infertility; however, these methods are labor-intensive, expensive, and laboratory-based. Cultural and socially dominated stigma against male infertility testing hinders a large number of men from getting tested for infertility, especially in resource-limited African countries. We describe the development and clinical testing of an automated smartphone-based semen analyzer designed for quantitative measurement of sperm concentration and motility for point-of-care male infertility screening. Using a total of 350 clinical semen specimens at a fertility clinic, we have shown that our assay can analyze an unwashed, unprocessed liquefied semen sample with <5-s mean processing time and provide the user a semen quality evaluation based on the World Health Organization (WHO) guidelines with ~98% accuracy. The work suggests that the integration of microfluidics, optical sensing accessories, and advances in consumer electronics, particularly smartphone capabilities, can make remote semen quality testing accessible to people in both developed and developing countries who have access to smartphones.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.